这个不起眼的信号，可能是肺癌扩散前的最后警报！很多人还以为是感冒

Core Viewpoint - Lung cancer is often misdiagnosed due to its non-specific early symptoms, leading to delayed treatment and poor outcomes. Awareness of early warning signs and proactive screening can significantly improve survival rates. Group 1: Early Symptoms of Lung Cancer - Persistent cough lasting more than 2 weeks or changes in cough characteristics, such as from occasional to frequent or from non-productive to blood-streaked sputum, are common initial symptoms [3][4] - Unexplained chest tightness, shortness of breath, or chest pain, particularly if worsened by activity, should be taken seriously [3] - Hemoptysis or blood-streaked sputum is a critical warning sign that necessitates immediate medical attention [4] - Unexplained weight loss, fatigue, and fever are often seen in late-stage patients, who may mistakenly attribute these symptoms to fatigue [5] Group 2: High-Risk Groups for Lung Cancer - Long-term smokers, including those exposed to secondhand and thirdhand smoke, are at significantly higher risk, with a risk increase of 10-20 times for heavy smokers [8] - Individuals with a family history of lung cancer, especially if a direct relative was diagnosed before age 60, face increased risk [8] - Those with prolonged exposure to dust and chemicals, such as miners and construction workers, are also at higher risk [9] - Individuals aged 40 and above are in a higher incidence category for lung cancer [10] Group 3: Screening and Detection - Standard chest X-rays have limited resolution and may miss early-stage lung cancer, particularly nodules smaller than 1 cm [12][13] - Low-dose spiral CT is the gold standard for lung cancer screening, with a radiation dose about one-fifth that of standard CT, significantly improving detection rates for nodules over 0.5 cm [13] - High-risk individuals are advised to undergo annual low-dose spiral CT screenings starting at age 40 to catch potential issues early [13] Group 4: Treatment Options - Early-stage lung cancer is primarily treated with surgery, with many patients achieving a 5-year survival rate of over 80% [15] - Intermediate-stage lung cancer typically involves a combination of surgery, chemotherapy, and radiation therapy, yielding favorable outcomes for many patients [15] - Advanced lung cancer patients with specific genetic mutations can benefit from targeted therapies, while those without mutations may find immunotherapy combined with chemotherapy effective [16] - Continuous treatment and regular follow-ups can allow patients, even those diagnosed at later stages, to maintain a good quality of life [16]